Gene · 5154
Papers4,148
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,148
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors. | Mol Cell Biochem | 2024 | 37016182 | PubTator, text mining | PubMed |
| There and back again: 50 years of wandering through terra incognita fusorum. | Exp Physiol | 2024 | 36628601 | PubTator, text mining | PubMed |
CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. | Pharmaceuticals (Basel) | 2023 | 38275995 | PubTator, text mining | PubMed |
| Comprehensive analysis of an endoplasmic reticulum stress-related gene prediction model and immune infiltration in idiopathic pulmonary fibrosis. | Front Immunol | 2023 | 38274787 | PubTator, text mining | PubMed |
| Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders. | Front Cell Neurosci | 2023 | 38273973 | PubTator, text mining | PubMed |
| Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment. | Front Chem | 2023 | 38264122 | PubTator, text mining | PubMed |
| Fecal Supernatants from Patients with Crohn's Disease Induce Inflammatory Alterations in M2 Macrophages and Fibroblasts. | Cells | 2023 | 38201264 | PubTator, text mining | PubMed |
| The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? | Cells | 2023 | 38201248 | PubTator, text mining | PubMed |
| A bibliometric and visual analysis of cancer-associated fibroblasts. | Front Immunol | 2023 | 38173726 | PubTator, text mining | PubMed |
| Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion. | iScience | 2023 | 38162029 | PubTator, text mining | PubMed |
| Advances in Diagnostic Tools and Therapeutic Approaches for Gliomas: A Comprehensive Review. | Sensors (Basel) | 2023 | 38139688 | PubTator, text mining | PubMed |
| Thrombocytes and Platelet-Rich Plasma as Modulators of Reproduction and Fertility. | Int J Mol Sci | 2023 | 38139165 | PubTator, text mining | PubMed |
| Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study. | Int J Mol Sci | 2023 | 38139123 | PubTator, text mining | PubMed |
| Paracrine Responses of Cardiosphere-Derived Cells to Cytokines and TLR Ligands: A Comparative Analysis. | Int J Mol Sci | 2023 | 38139105 | PubTator, text mining | PubMed |
| All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia. | Medicina (Kaunas) | 2023 | 38138273 | PubTator, text mining | PubMed |
| Targeting of the NOX1/ADAM17 Enzymatic Complex Regulates Soluble MCAM-Dependent Pro-Tumorigenic Activity in Colorectal Cancer. | Biomedicines | 2023 | 38137406 | PubTator, text mining | PubMed |
| Stiffness-induced cancer-associated fibroblasts are responsible for immunosuppression in a platelet-derived growth factor ligand-dependent manner. | PNAS Nexus | 2023 | 38111825 | PubTator, text mining | PubMed |
| Creeping fat exhibits distinct Inflammation-specific adipogenic preadipocytes in Crohn's disease. | Front Immunol | 2023 | 38111581 | PubTator, text mining | PubMed |
| Spatial architecture of high-grade glioma reveals tumor heterogeneity within distinct domains. | Neurooncol Adv | 2023 | 38077210 | PubTator, text mining | PubMed |
| MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches? | Cancers (Basel) | 2023 | 38067261 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5154/papers?page=9